Oka Y - Search Results

1

The endoplasmic reticulum stress-inducible protein, Herp, is a potential triggering antigen for anti-DNA response.

Hirabayashi Y, Oka Y, Ikeda T, Fujii H, Ishii T, Sasaki T, Harigae H. Hirabayashi Y, et al. Among authors: oka y. J Immunol. 2010 Mar 15;184(6):3276-83. doi: 10.4049/jimmunol.0900670. Epub 2010 Feb 10. J Immunol. 2010. PMID: 20147634

2

A monoclonal antibody against human homocysteine-induced endoplasmic reticulum protein (Herp): a useful tool for evaluating endoplasmic reticulum stress.

Oka Y, Hirabayashi Y, Ishii T, Takahashi R, Sasaki T. Oka Y, et al. Tohoku J Exp Med. 2007 Aug;212(4):431-7. doi: 10.1620/tjem.212.431. Tohoku J Exp Med. 2007. PMID: 17660709 Free article.

3

A potential trigger of nephritogenic anti-DNA antibodies in lupus nephritis.

Hirabayashi Y, Oka Y, Tada M, Takahashi R, Ishii T. Hirabayashi Y, et al. Among authors: oka y. Ann N Y Acad Sci. 2007 Jun;1108:92-5. doi: 10.1196/annals.1422.010. Ann N Y Acad Sci. 2007. PMID: 17893974

4

Reversible bone marrow dysplasia in patients with systemic lupus erythematosus.

Oka Y, Kameoka J, Hirabayashi Y, Takahashi R, Ishii T, Sasaki T, Harigae H. Oka Y, et al. Intern Med. 2008;47(8):737-42. doi: 10.2169/internalmedicine.47.0607. Epub 2008 Apr 16. Intern Med. 2008. PMID: 18421190 Free article.

5

A single-stranded DNA-cross-reactive immunogenic epitope of human homocysteine-inducible endoplasmic reticulum protein.

Oka Y, Hirabayashi Y, Ikeda T, Fujii H, Ishii T, Harigae H. Oka Y, et al. Scand J Immunol. 2011 Sep;74(3):296-303. doi: 10.1111/j.1365-3083.2011.02572.x. Scand J Immunol. 2011. PMID: 21535081 Free article.

6

The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.

Hirabayashi Y, Ishii T; Michinoku Tocilizumab Study Group. Hirabayashi Y, et al. Clin Rheumatol. 2013 Jan;32(1):123-7. doi: 10.1007/s10067-012-2103-4. Epub 2012 Oct 23. Clin Rheumatol. 2013. PMID: 23090655 Free PMC article.

7

Clinical efficacy of belimumab in patients with systemic lupus erythematosus and headache. A report of two cases.

Kodera T, Tsutsumi T, Oka Y, Takeda T, Shirota Y, Kameoka J. Kodera T, et al. Among authors: oka y. Mod Rheumatol Case Rep. 2022 Jan 7;6(1):25-28. doi: 10.1093/mrcr/rxab003. Mod Rheumatol Case Rep. 2022. PMID: 34505625

8

[Three cases of systemic sclerosis-associated gastrointestinal dysfunction that were improved with oral bovine type II collagen].

Asaoka T, Suzuki T, Oka Y. Asaoka T, et al. Among authors: oka y. Nihon Rinsho Meneki Gakkai Kaishi. 1999 Apr;22(2):93-9. doi: 10.2177/jsci.22.93. Nihon Rinsho Meneki Gakkai Kaishi. 1999. PMID: 11126660 Japanese.

9

Decrease of infectious complications in outpatients with autoimmune diseases from 2019 to 2020 under the COVID-19 pandemic: A single-centre, retrospective cohort study in Japan.

Oka Y, Kodera T, Takeshita M, Shirota Y, Takeda T, Tsutsumi T, Kameoka J. Oka Y, et al. Mod Rheumatol. 2022 Feb 28;32(2):444-451. doi: 10.1093/mr/roab080. Mod Rheumatol. 2022. PMID: 34918128 Free PMC article.

10

Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report.

Furukawa H, Nomura J, Kobayashi M, Abe S, Takeda T, Oka Y, Shirota Y, Kodera T, Okitsu Y, Takahashi S, Murakami K, Kameoka J. Furukawa H, et al. Among authors: oka y. Tohoku J Exp Med. 2023 Jan 21;259(2):113-119. doi: 10.1620/tjem.2022.J104. Epub 2022 Dec 1. Tohoku J Exp Med. 2023. PMID: 36450481 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,688 results

Search Page

Filters